WallStSmart

BK Technologies Inc (BKTI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 201% more annual revenue ($258.90M vs $86.14M). BKTI leads profitability with a 15.7% profit margin vs -15.5%. BKTI earns a higher WallStSmart Score of 55/100 (C).

BKTI

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 9.0Value: 6.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BKTIUndervalued (+22.9%)

Margin of Safety

+22.9%

Fair Value

$106.52

Current Price

$96.36

$10.16 discount

UndervaluedFair: $106.52Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BKTI2 strengths · Avg: 9.0/10
Return on EquityProfitability
36.3%10/10

Every $100 of equity generates 36 in profit

Revenue GrowthGrowth
20.0%8/10

Revenue surging 20.0% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BKTI3 concerns · Avg: 3.7/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Price/BookValuation
8.1x4/10

Trading at 8.1x book value

Market CapQuality
$360.79M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BKTI

The strongest argument for BKTI centers on Return on Equity, Revenue Growth. Profitability is solid with margins at 15.7% and operating margin at 19.7%. Revenue growth of 20.0% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BKTI

The primary concerns for BKTI are P/E Ratio, Price/Book, Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

BKTI profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMMUNICATION EQUIPMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BKTI scores higher overall (55/100 vs 41/100), backed by strong 15.7% margins and 20.0% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BK Technologies Inc

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

BK Technologies Corporation, through its subsidiary, BK Technologies, Inc., designs, manufactures, and markets wireless communications products in the United States and internationally. The company is headquartered in West Melbourne, Florida.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?